Close
Close
Treatment Database
Recombinant human IgG1 kappa light chain monoclonal antibody targeting plasma kallikrein
Trade Name TAKHZYRO
Orphan Indication Hereditary angioedema
EU Market Approval 26-11-2018
EU Designation Date 09-10-2015
Sponsor Shire Pharmaceuticals Ireland Limited
More about Hereditary angioedema
Free Newsletter
Related Videos
by Abidemi Uruejoma
296 views
by Abidemi Uruejoma
626 views
by Abidemi Uruejoma
620 views
by Abidemi Uruejoma
886 views
by Abidemi Uruejoma
4,518 views